Adjuvant Chemotherapy In Elderly With Colon Cancer Stage III
Status:
Active, not recruiting
Trial end date:
2032-01-01
Target enrollment:
Participant gender:
Summary
This is a phase 2, randomized study where the aim of the study is to investigate the
tolerance of adjuvant chemotherapy, measured by functional decline, after surgery for colon
cancer stage III in elderly patients. Secondary aims are disease-free survival, toxicity,
late functional outcome, quality of life, to establish a geriatric assessment for selection
of patients, and to examine the prognostic value of gene signature tests / biomarkers for
stage III colon cancer.